Key result
Underweight with stage 2/3 hypertension linked to ~400% higher MACE risk vs normal weight and BP.
Why the study?
Co-occurring obesity and hypertension carries high cardiovascular risk, but the prognostic significance of underweight in the presence of hypertension remains uncertain.
Does underweight status modify the risk of major adverse cardiovascular events across different blood pressure categories in adults without prior cardiovascular disease?
Cohort (n=6,262,298)
Yes
Does underweight status modify the risk of major adverse cardiovascular events across different blood pressure categories in adults without prior cardiovascular disease?
Underweight status significantly amplifies the risk of major adverse cardiovascular events in patients with hypertension, highlighting a high-risk phenotype that may be overlooked in standard cardiovascular prevention strategies.
Answers are grounded in this paper and cite their sources.
Underweight adults with stage 2/3 hypertension warrant careful risk assessment; extends obesity-focused data but leaves open causal mechanisms and targeted interventions.
Co-occurring obesity and hypertension is associated with high cardiovascular risk, whereas the prognostic significance of underweight in the presence of hypertension remains uncertain. We examined whether the association between body mass index category and 10-year risk of major adverse cardiovascular events differed across blood pressure categories. Using the Japan Medical Claims Database from 2005 to 2023, we analyzed 6,262,298 adults without prior cardiovascular disease, chronic renal failure, dialysis, or antihypertensive medication use at baseline. Blood pressure was classified as normal (<120 and <80 mmHg), high-normal (120–129 and <80 mmHg), elevated (130–139 and/or 80–89 mmHg), stage 1 hypertension (140–159 and/or 90–99 mmHg), or stage 2/3 hypertension (≥160 and/or ≥100 mmHg). Body mass index was classified as underweight (<18.5 kg/m²), normal weight (18.5–24.9), overweight (25.0–29.9), or obesity (≥30.0). The primary outcome was major adverse cardiovascular events within 10 years. Multivariable Cox proportional hazards models estimated hazard ratios for combined blood pressure and body mass index categories, using normal blood pressure with normal weight as the reference. During a median follow-up of 1,183 days, 34,034 participants experienced major adverse cardiovascular events. Underweight showed a marked blood pressure-dependent increase in risk, with the hazard ratio rising from 1.14 (95% confidence interval, 1.07–1.22) in normal blood pressure to 5.01 (4.23–5.93) in stage 2/3 hypertension. The interaction between blood pressure category and body mass index category was significant. These findings suggest that higher blood pressure may amplify the adverse prognostic significance of underweight.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (2026) conducted a cohort in Hypertension and Underweight (n=6,262,298). Underweight combined with stage 2/3 hypertension vs. Normal weight with normal blood pressure was evaluated on Major adverse cardiovascular events (MACEs) within 10 years (HR 5.01, 95% CI 4.23-5.93, p=<0.01). Underweight combined with stage 2/3 hypertension significantly increased the risk of major adverse cardiovascular events (HR 5.01) compared to normal weight with normal blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: